Figure 8.
Bacterial colonies of clinical strains MRSA-20 grown on Congo red agar plates, showing decreasing levels of slime production in the presence of CAB extracts at BIC (100 μg/mL): (a) strong black colour colonies of untreated MRSA-20; (b) MRSA-20 treated with CAB-E2; (c) MRSA-20 treated with CAB-E4 at BIC.